SAN DIEGO, May 12 Neurocrine Biosciences, Inc.(Nasdaq: NBIX) announced today that Neurocrine Biosciences will present at theCiti Investment Research Global Health Care Conference at the Hilton New York.The live presentation takes place Thursday, May 22, 2008 at 3:00 p.m. EasternTime (ET) /12:00 p.m. Pacific Time (PT). The presentation will besimultaneously webcast and may be accessed on the Company's website athttp://www.neurocrine.com
If you are unable to attend the webcast and would like further informationon this announcement please contact the Investor Relations Department atNeurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit thewebsite approximately 5 minutes prior to the presentation to download orinstall any necessary software. A replay of the presentation will be availableapproximately one hour after the conclusion of the live event and will bearchived on the website for two weeks.
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused onneurological and endocrine diseases and disorders. Our product candidatesaddress some of the largest pharmaceutical markets in the world includingendometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain,diabetes, benign prostatic hyperplasia (BPH) and other neurological andendocrine related diseases and disorders. Neurocrine Biosciences, Inc. newsreleases are available through the Company's website via the internet athttp://www.neurocrine.com
SOURCE Neurocrine Biosciences, Inc.